Paychex, Inc. vs GeneDx Holdings Corp — how do they compare? Paychex, Inc. trades at $111.32 (market cap $39.82B), while GeneDx Holdings Corp trades at $61.39 (market cap $1.83B). The key difference: Paychex, Inc. is far larger — about 21.8× GeneDx Holdings Corp's market cap, and Paychex, Inc. pays a 4.25% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| PAYX | WGS | |
|---|---|---|
Market Cap | $39.82B | $1.83B |
Sector | Industrials | Technology |
52-Week High | $147.99 | $167.51 |
52-Week Low | $85.57 | $34.51 |
Enterprise Value | $43.31B | $1.83B |
Dividend Yield | 4.25% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Trailing returns across standard periods
Latest headlines on both assets
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →